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http://www.biomedcentral.com/1472-684X/13/55STUDY PROTOCOL Open AccessThe study protocol of: ‘Initiating end of life care in
stroke: clinical decision-making around prognosis’
Christopher R Burton1*, Sheila Payne2, Mary Turner2, Tracey Bucknall3, Jo Rycroft-Malone1, Pippa Tyrrell4,
Maria Horne5, Lupetu Ives Ntambwe1, Sarah Tyson6, Helen Mitchell7, Sion Williams1 and Salah Elghenzai8Abstract
Background: The initiation of end of life care in an acute stroke context should be focused on those patients and
families with greatest need. This requires clinicians to synthesise information on prognosis, patterns (trajectories) of
dying and patient and family preferences. Within acute stroke, prognostic models are available to identify risks of
dying, but variability in dying trajectories makes it difficult for clinicians to know when to commence palliative
interventions. This study aims to investigate clinicians’ use of different types of evidence in decisions to initiate end
of life care within trajectories typical of the acute stroke population.
Methods/design: This two-phase, mixed methods study comprises investigation of dying trajectories in acute
stroke (Phase 1), and the use of clinical scenarios to investigate clinical decision-making in the initiation of palliative
care (Phase 2). It will be conducted in four acute stroke services in North Wales and North West England. Patient
and public involvement is integral to this research, with service users involved at each stage.
Discussion: This study will be the first to examine whether patterns of dying reported in other diagnostic groups
are transferable to acute stroke care. The strengths and limitations of the study will be considered. This research will
produce comprehensive understanding of the nature of clinical decision-making around end of life care in an acute
stroke context, which in turn will inform the development of interventions to further build staff knowledge, skills
and confidence in this challenging aspect of acute stroke care.
Keywords: Acute stroke, Palliative care, End of life care, Decision making, Dying trajectories, ImplementationBackground
Despite significant advances in the organisation and con-
tent of stroke services, nearly 20% of patients will die in
the acute phase; 11% of all deaths in England and Wales
are due to stroke [1]. Stroke services are required to
ensure that best end of life care, usually defined within
a cancer context, is implemented [2]. However, the
rehabilitation practice context may seem at odds with
palliative care, and the evidence base to guide this in
stroke is lacking [3]. In a previous study to address a
lack of prospective information on patient and family
needs, we demonstrated that acute stroke patients have
a high burden of problems that the principles of palliative
care can address [4]. For example, in a consecutive sample
of acute stroke admissions, over 50% reported moderate* Correspondence: c.burton@bangor.ac.uk
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unless otherwise stated.to significant fatigue-related problems, symptom-related
problems such as pain, or psychological distress. Approxi-
mately one in every four patients had concerns about
death or dying.
Although knowledge of factors that predict acute
stroke mortality is available [5], recognition of a stroke
patient’s ‘dying’ status may be ambiguous [6], potentially
resulting in over or under treatment and delaying initi-
ation of general palliative care or referral to specialist
palliative care. Older people may be disadvantaged when
accessing appropriate and acceptable services that meet
their preferences and those of their family carers, who
may also be older people [7]. A specific challenge is the
initiation of end of life care [6]. There are problems in
recognising the process of dying and assigning an entry
point to ‘end of life’ is always going to be somewhat arbi-
trary [8]. Hypothesised models of typical dying trajector-
ies linked to cancer, organ failure and frailty have not
always been supported by empirical data [9,10]. EarlierLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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or have focused on psychosocial transitions [12] alone.
More recently other models have been proposed to cap-
ture the fluctuations in palliative care input relative to
other healthcare interventions, including curative treat-
ment [13,14], reinforcing the need for a seamless inte-
gration of palliative and end of life care within the acute
stroke pathway.
Inevitably, acute stroke onset presents a significant
threat to patients and families, and these impacts are
well documented in the literature. Although most pa-
tients survive acute stroke, patients and their families
have concerns about death and dying that do not appear
to be related to prognosis [6]. Opportunities to discuss
and help make sense of these concerns may be import-
ant, and any uncertainty about prognosis should not
prevent these issues from being explored. Dealing with
end of life issues places considerable demands on pa-
tients and family members; the role of clinicians in this
context is to initiate timely and effective support to help
patients and families cope with and adapt to these de-
mands. Policy and clinical guidance both highlight the
importance of information provision, communication
and decision-making within a multi-disciplinary context,
and partnership with patients and families to determine
care preferences [15,16]. However, the implementation
of evidence-based guidelines around palliative and end
of life care in stroke is complex [17], with staff-related
challenges including professional beliefs about legitimacy
of palliative care; confidence and skills; engaging with
family members; recognising dying and knowing when
to commence end of life care interventions.
The major emphasis of acute stroke care is on ensuring
neurological recovery or stability, preventing complications
and commencing early rehabilitation [18]. Patients and
families also require access to professional interventions
that ameliorate negative disease sequelae, and support
them during a potentially life threatening event. However,
the evidence base for the effectiveness of supportive strat-
egies to address these issues in stroke is diffuse, and lacking
in any theoretical integrity [19]. There appears to be a
dilemma for staff when considering the nature and purpose
of end of life care in acute stroke services, including
whether end of life care focuses predominantly on death,
or more supportive interventions that could (or not) be
combined with active treatment strategies to improve the
quality of an individual’s limited life. A discourse around
'supportive care' may provide an acceptable middle-ground
where staff could see the value of palliative care in promot-
ing 'quality of life' rather than merely 'a good death'.
Reflecting on frameworks from the implementation lit-
erature (e.g. [20]), the use of information in end of life
care is a function of the interplay between the different
types of evidence used by clinicians to inform decisions;individual and organisational influences on use; and the
tools and strategies through which use is enabled. Dying
trajectories in acute stroke, prognostic factors associated
with each trajectory, and service user preferences for the
initiation of end of life care within and across trajectories
provide a mix of evidence to guide clinical practice [21].
Decision science studies the cognitive processes underpin-
ning the selection of evidence, specifically the filtering and
integration of current scientific information into changing
contexts [22]. However, Downie and Macnaughton [23]
suggest that scientific facts only become evidence when
the clinician decides the information is relevant to a
particular case. In Hogarth’s [24] model of decision
making, individual characteristics such as personal attri-
butes, values and capabilities, the complexity of the task
and the external environment all shape the behaviour of
the decision maker. This study will provide a novel op-
portunity to investigate the different types of evidence
used by individual clinicians in making decisions on end
of life care. The outcomes of the study will inform our
understanding of end of life decision making and en-
hance the transferability of findings to other, related
diagnostic groups.The study
Aims and objectives
The overall aim of the study is to investigate clinicians’
use of different types of evidence in decisions to initiate
end of life care within trajectories typical of the acute
stroke population.
The specific objectives are:
 To identify trajectories of dying in acute stroke;
 To investigate patients’ and family members’
experiences of the initiation of end of life care
within acute stroke;
 To identify how clinicians draw on different types of
prognostic, clinical and other information sources
used in making decisions about initiating end of life
care in acute stroke; and
 To determine the influences on clinical decisions
concerning end of life care in acute stroke.Methods/Design
This is a two-phase, mixed methods study comprising
investigation of dying trajectories in acute stroke (Phase
1), and the use of clinical scenarios to investigate clin-
ical decision-making in the initiation of end of life care
(Phase 2). We will be guided by a steering group com-
prising the research team and collaborators, with repre-
sentation from regional Patient and Public Involvement
(PPI) groups.
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We have consulted and will continue to consult with
PPI representatives and with people living with stroke in
North West England and North Wales. Consultation in-
cludes issues around the study ‘language’, the acceptabil-
ity of recruitment processes, and the content and
structure of interview schedules. In addition, two mem-
bers of the Lancaster Research Partners Forum (a group
of service users with training in research appreciation)
have joined the project team.
Phase 1
This phase is an observational patient tracking study to
identify dying trajectories within acute stroke, with inter-
views of a sub-sample of patients and/or carers and be-
reaved carers to explore views about the initiation of end
of life care. For the purposes of this study, acute stroke
is defined as the first 28 days after stroke onset [25]. Pat-
terns of dying across a range of conditions have been de-
scribed qualitatively, but have yet to be specified in an
acute stroke population. Our starting point for the de-
velopment of dying trajectories will be an adaptation of
the four trajectories identified by Lunney et al. [9] and
proposed for use in non-malignant diseases [26]. This
typology is underpinned by a grounded theory study
[27], and has been used for the retrospective classifica-
tion of dying trajectories across a large sample of older
decedents in the US. We will use the same sequential
profiling methods as Lunney et al. [9] to allocate dece-
dent patients to an individual trajectory, although the
clinical markers we will use are different, and will be val-
idated by the research team and study collaborators.
Initially, patient deaths will be classified by the lead
stroke clinician as Trajectory 1 or not. Where there is
evidence of a distinct terminal phase, then deaths will be
classified as Trajectory 2. For remaining patient deaths,
where there is evidence of multiple professional inputs
designed to address a specific problem, then these will
be classified as Trajectory 3. The remaining deaths will
be classified as Trajectory 4, or ‘other’ where it is not
possible to classify using the textual descriptions of each
Trajectory type (see Table 1).Table 1 Typology of potential dying trajectories in acute stro
Markers from Lunney et al. 2002 [9]
1 Sudden Little evidence of healthcare in the last year of life
2 Rapid death Plurality of physician input in last year of life
3 Episodic Evidence of multiple acute interventions; exacerbat
of health problems; evidence of organ failure
4 Slow decline Frailty associated with long-term health condition
5 OtherSetting and participants
The first phase of the study is being conducted over a
six month period in four acute stroke services (three in
North Wales and one in North West England). We aim
to include 832 patients, and estimate that 141 of these
patients may die in the acute stroke phase. In addition,
semi-structured interviews of a sub-sample of up to 30
patients, family carers and bereaved relatives will un-
cover associated chronological narratives of experience.
Inclusion criteria
All patients with a clinical diagnosis of acute stroke, con-
firmed by a lead clinician through entry into the acute
stroke register, will be eligible for inclusion in the study.
Patients presenting with subarachnoid haemorrhage, or
who are unable to consent with no personal consultee, will
be excluded. Individuals that self-identify as family carers
of a patient will be able to participate in interviews.
Data collection
Soon after admission, potential participants and their
family members will be introduced to the study by a
member of the clinical team, and provided with a study
information pack. This pack includes information about
the purpose of the study and details of what will happen
to them if they decide to take part. If patients and/or
family members are interested in participating, they will
be asked to leave an expression of interest form in a
sealed envelope with a member of the clinical team. For
those patients who wish to take part, a member of Re-
search Network staff will meet with them in hospital to
take their consent. Once consent/consultation has been
recorded, the patients’ GP will be informed of their par-
ticipation in the study.
For patients unable to consent for themselves, a family
member able to advise on the presumed wishes of the
patient will be approached to act in the role of consultee.
This is in line with the recommendations of the Mental
Capacity Act 2005 [28] and also with the expressed
wishes of patient and public involvement representatives,
who would like everyone who is eligible to have the op-
portunity to participate.ke
Proposed typology
Unexpected death - e.g. ineffective resuscitation; complications
of thrombolysis; overwhelming cardio/cerebrovascular event
Expected death; distinct terminal phase although not
set within a general context of deterioration
ions Evidence of increasing health problems; multiple acute,
curative interventions; indistinct terminal phase
Multiple health problems; general picture of persisting,
and overwhelming illness
Unable to classify as above
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Research Network staff. These will extract the minimum
data outlined in Table 2 for every acute stroke admission
from each hospital’s database of stroke admissions. This
will allow a minimum amount of non-identifiable data
to be collected to enable the mapping of different dying
trajectories. For patients that consent, a range of bio-
graphical and clinical information will be extracted from
the patients’ hospital records. This will include informa-
tion about them and their family, their health, and the
care they received whilst in hospital or from their GP. In
addition, the research staff will also complete an assess-
ment of the dying trajectory for patients that die within
the acute stroke phase.
Some participants will be invited to take part in an inter-
view to explore their experiences and preferences for care.
Interviews will draw on individually meaningful markers
to identify the initiation of end of life care (e.g. informa-
tion provision, withdrawal of interventions), and the way
that this impacts upon experiences of care and illness pro-
gression. These interviews will be conducted in hospital orTable 2 Phase 1 data collection summary
All eligible patients Consented patients
Patient age at stroke event Name
Gender Address
Date of stroke event Contact details
Stroke subtype Marital status
Date of admission Living accommodation
Date and destination of transfer of care Presence of family carer
Date and primary/secondary causes
of death date of admission
On admission:
Presence of Advance Care Plan
Dying trajectory type
(completed by clinical staff)
Co-morbidities (Number)
Modified Rankin
Barthel Index
Communication
Cognition
During acute stroke phase:
Number and type of palliative o
and evidence of referrals implem
Use of DNR orders, including da
with family/implementation
Use of End of Life Pathway, incl
Dying trajectory type (complete
and clinical staff)at home, dependent on participant preference, and may
include a family carer if the patient wishes, or has add-
itional communication support needs. We will also inter-
view a small number of family members of patients who
have died from their acute stroke. As with the National
Bereavement Survey [29], we will not contact family mem-
bers in these circumstances until at least three months
after the death. These interviews will be conducted by an
experienced palliative care researcher in the participant’s
home or other place of their choosing.
Data analysis
The data will be used to construct typologies of ‘patterns
of dying’ or trajectories after stroke. We will use these typ-
ologies to develop case scenarios for a subsequent investi-
gation of clinical decision-making around end of life care.
Quantitative data will be analysed using SPSS software.
Analysis will commence with the production of descrip-
tive statistics (central tendency and variation for interval
data; frequencies and percentages for categorical data)
and appropriate graphical summaries for recruitmentInterviews with up to 10 consented patients:
Date of interview
Interviewer reflections on interview
Interview transcript
Interviews with up to 5
bereaved family relatives:
Date of interview
Interviewer reflections on interview
Interviewer transcript
r end of life referrals,
ented
te of discussion
uding start date
d by research
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each clinical site. T-tests or Chi Square tests will be used
where relevant to identify important differences in the
samples across each clinical site. The remainder of the
analyses will be conducted on the dataset as a whole.
The main analyses will focus on the detailed investiga-
tion of patients who die within the acute stroke phase.
The purpose of the analysis is not to evaluate any of the
prognostic models for acute stroke mortality that can be
found in the literature. Rather it is to provide an inte-
grated overview of the different dying trajectories which
may be observed.
Initially the inter-rater reliability between study and
clinical staffs’ assessment of dying trajectories will be
assessed using the kappa statistic [30]. For subsequent
analyses, only the assessment of trajectory type by clin-
ical staff will be used. The analyses will include a de-
scription of each trajectory, including where possible the
production of Kaplan Meier curves for the subset of pa-
tients who died within each of the trajectories. Univari-
ate analyses of key patient, clinical and service variables
across each trajectory type will be performed. The final
analytical task will be to produce a narrative of the dif-
ferent trajectories which may be observed. This narrative
will juxtapose patient and clinical variables and summar-
ies of service provision with data on the time to death
and cause of death through the use of charts [31].
Interview transcripts, interviewer reflections and any
field notes will be managed in NVivo software. Com-
monalities and differences within individual accounts
(patients, current family carers and bereaved relatives)
and across the four acute stroke services will be identi-
fied. The analysis will be iteratively influenced by the lit-
erature and the outcomes from the observational study
to maximise interpretive depth, and ensure that the di-
versity of dying trajectories in stroke is fully addressed.
An initial framework of thematic categories will be ap-
plied to interview data drawing on the research objec-
tives. Constant comparison will be used so that the early
stages of analysis inform subsequent data collection. The
aim of the analysis will be to produce insights relating to
the research questions which are grounded in the expe-
riences and understandings of the participants, and
which are capable of theoretical or logical generalisation.
We will explore the extent to which findings from the
thematic analysis and the observational dataset analysis
are congruent. We will use both findings to postulate
dying trajectories in stroke comprising detailed descrip-
tions of patient, family and clinical perspectives.
Phase 2
This phase will describe the clinical decisions about end
of life care using a ‘think aloud’ approach [32]. This
technique examines the information used by individualswhen making clinical decisions, providing insight into
factors that influence decisions, together with the final
judgements and decisions made by an individual. Partici-
pants will also be asked to complete a second, follow-on
interview to explore how clinicians make decisions about
initiating end of life care, the information that they use,
and the influences on these decisions.
Setting and participants
Up to 30 clinicians from stroke units in four hospitals in
North Wales and North West England will take part. Par-
ticipants will reflect a mix of professional roles, experience
and qualifications; however, recruitment will focus on clini-
cians who have responsibility for decision-making within
the multidisciplinary team. This is most likely to be doctors,
clinical nurse specialists and senior ward staff, but might
also include senior allied health professionals. Participants
will be purposively sampled from each stroke service.
Recruitment
The research team already has established links with
stroke physicians and specialist nurses at each hospital
site, and with the assistance of these individuals the re-
search team will compile a list of key members of the
multidisciplinary stroke team at each site.
Following ethical and governance approvals, stroke
team members will be provided with information packs
about the study and asked to distribute them amongst
their colleagues. The packs will include an invitation let-
ter, study information sheet, expression of interest form,
consent form and return envelope. Potential participants
will be asked to complete the expression of interest form
and return it, either by post in the envelope provided or
by email, to the research team. A researcher will then
contact the participant and arrange a mutually conveni-
ent time and place for interviews to take place.
Data collection
Think-aloud exercise
The ‘think-aloud exercise’ will use a clinical scenario, a
standard method in decision-making research, to exam-
ine the prognostic and other information and cognitive
processes that staff use when making judgements and
decisions [33].
To begin with, participants will be taken through a prac-
tice exercise: they will be asked to visualise walking into
their home through their front door, and then asked to de-
scribe the route they would take whilst counting the num-
ber of windows in each room. Participants will then be
given a decision task and asked to ‘think aloud’ or verbal-
ise everything they are thinking whilst carrying out the
task [34]. Critical to this is the development of the deci-
sion task: we will use case scenarios to represent the types
of patients and decision scenarios that clinicians are faced
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‘vignettes’ will be developed from Phase 1 data and from
the clinical expertise of the project team to resemble as
closely as possible the types of information clinicians
would normally have access to [35,36]. Case scenarios will
be tested for face and content validity with an expert panel
(n = 5) experienced in end of life care in acute stroke iden-
tified through the UK Stroke Research Network. Partici-
pants will be asked to think aloud whilst developing a
management plan for the patient described in the sce-
nario. These verbalisations will be recorded and tran-
scribed. To compare decision making across participants,
the same set of clinical scenarios will be used.
Prompts used in the think-aloud exercise will focus on
participants’ thinking rather than actions per se. Where
more information is requested, then the nature of infor-
mation required, and how this might influence thinking
will be explored, and where required, the scenario will
be used to shift discussion from the general to the spe-
cific. The scenario will not make explicit reference to
end of life care. If this is not mentioned by participants,
then the interviewer will ask the question, “Would you
be thinking that this patient might die?” to complete the
think aloud exercise.
Semi-structured interviews
All participants in the think-aloud exercise will subse-
quently be interviewed to explore in more detail their
perceptions about how they make decisions about initi-
ating end of life care, and the information that they
think they use, including specific challenges they cur-
rently face in practice. Participants will be asked to ex-
pand on management plans they developed during the
think-aloud exercise to provide a detailed exploration of
the factors influencing their decision making. Again, all
interviews will be digitally recorded and transcribed.
As it is expected that the ‘think-aloud’ exercise will
take around 30 minutes to complete, participants will be
offered the option of taking part in the interview on an-
other day and/or by telephone, in order to minimise the
burden on participants. If preferred, the interview could
be run as a focus group with different members of the
multidisciplinary team taking part together.
Data analysis
Think-aloud study data will be analysed using protocol
analysis, an established technique for identifying the in-
formation and specific cognitive processes that individ-
uals have used to make decisions [34]. It involves the
categorisation of each element of verbalisation into mu-
tually exclusive categories corresponding to a cognitive
process (e.g. information seeking). After this analysis, it
is possible to analyse different elements of the judge-
ment and decision process (e.g. the information used toinform the decision) and to map the order in which ele-
ments of the decision process occur [36]. The analysis
will enable us to compare decision making across clini-
cians, areas of consensus and disagreement.
Interview data will be analysed using thematic analysis
[37]. Transcripts from the interviews will be read to
identify themes or categories to code the data, and then
examined to explore interconnections between themes
[38]. The results of the analysis from the interview study
will then be synthesised with the protocol analysis pro-
viding a detailed insight into how staff use information,
and the factors that influence their decision making
about initiating end of life care. The analysis will identify
patterns of similarity and differences across individuals
and staff groups to explore implementation issues.Ethical considerations
Research into end of life care can raise many ethical and
professional challenges, particularly around how research
is presented to potential participants. Ethical approval for
Phase 1 of the study was given by the National Institute
for Social Care and Health Research (NISCHR) North
Wales Research Ethics Committee West on 26 March
2013 (reference 13/WA/0086) and two substantial amend-
ments to add further measures to the protocol were ap-
proved on 11 July 2013 and 3 February 2014. Approval for
Phase 2 was given by the Healthcare and Medical Sciences
Academic Ethics Committee at Bangor University on 22
May 2014. Written informed consent will be obtained
from all study participants (or their consultees). The team
have considerable experience in addressing ethical chal-
lenges in end of life care and stroke research, including
conducting and supervising interviews that may poten-
tially be distressing for patients and families. Recruitment
and data collection processes have been designed to en-
sure that we place no additional stress on patients and
families. This includes the use of a ‘neutral’ study title that
does not use words such as ‘palliative’ that have loaded
meaning within public discourse. To mitigate the potential
for emotional burden, we will provide a supportive envir-
onment for research staff. Excellent communication skills
around stroke-related communication problems can be
addressed through the use of aphasia-friendly materials
and the use of communication aids within interviews.
Patient and public involvement is an important mech-
anism in confirming the acceptability of study documen-
tation. However, we have drawn on the skills of our
patient and public representatives in exploring the prac-
tical issues of approaching patients and families for con-
sent or consultation with research staff. In this way, we
hope to ensure that recruitment is maximised, with lim-
ited potential for clinician ‘gate-keeping’ to protect those
participants perceived as vulnerable by staff [39].
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Prognostic information on dying and understanding clini-
cians’ decision-making will maximise the implementation
potential for initiating end of life care in acute stroke. We
plan to prepare abstracts for submission to stroke (e.g.
UK Stroke Forum) and palliative care conferences (e.g.
European Association for Palliative Care research con-
ference) and to a range of professional and academic
journals. We will use EAPC blogs and stroke improve-
ment resources (e.g. UK Forum for Stroke Training) to
rapidly highlight study recommendations to clinicians.
Discussion
Information on prognostic factors may alert staff to
those patients who are at higher risk of death in the
acute stroke phase. However, this information alone may
be insufficient to enable staff to recognise impending
death, and to plan care that meets the preferences of pa-
tients and families in these circumstances. Rapid and un-
expected deaths provide little opportunity for staff to
implement anything other than palliative care at the very
end of life. Understanding of the complete range of pat-
terns of dying and survival may equip stroke service staff
with the knowledge and confidence to weave palliative
and end of life interventions into a patient’s programme
of care.
This study will be the first to examine whether pat-
terns of dying reported in other diagnostic groups are
transferable to acute stroke care. In addition the study
will explore the process of clinical decision-making in
this area. The study is located within the decision-
making and implementation literature, focusing on the
importance of context, and the breadth of evidence and
information that staff may draw on to guide their clinical
practice. Our intention is that an in-depth understand-
ing of the nature of clinical decision-making, coupled
with evidence of observable patterns of dying, will in-
form the development of interventions to further build
staff knowledge, skills and confidence in this challenging
aspect of acute stroke care.
The strengths of this study lie in the mix of methods,
which will simultaneously generate evidence of dying
trajectories, and the nature of associated clinical decision-
making by staff. Integrating both quantitative and quali-
tative perspectives on patterns of dying will provide a
comprehensive overview on which to base further re-
search. In addition, the mix of academic and profes-
sional disciplines, together with a service user voice,
will ensure that the implementation of this study and
the interpretation of findings are robust.
We should draw attention to some of the challenges
that have been experienced in setting up this study, or
that are anticipated. The study spans health services in
both England and Wales; both countries have separateresearch governance approval strategies and processes.
Although these are intended to dovetail as much as pos-
sible, the review requirements of each have complicated
the study set-up process. Attention has been paid to
strategies that enable participation in the study in ways
that maximise the collection of a minimum of data with
minimal inconvenience to patients. The challenge of en-
abling the participation of patients with more severe
strokes, and who may be at greater risk of death, should
not be underestimated. Permission has been granted to
obtain routine, anonymised data from all acute stroke
admissions, with consent (or consultation) required for
the collection of only additional data. However the col-
lection of these data, which may represent factors associ-
ated with the differing patterns of dying, which themselves
may vary in incidence, will depend on the ability of re-
search network staff to approach patients and families in a
timely manner.
This research will produce a comprehensive overview
of the nature of clinical decision-making around end of
life care in an acute stroke context. We aim to provide
clinicians with an understanding of the patterns of dying
in acute stroke, together with patient and family experi-
ences of end of life care. This will complement the avail-
able statistical models which are prognostic of acute
stroke mortality. Our hypothesis is that this combination
of evidence will improve quality in this challenging area
of practice. As interviews with staff will also explore the
context around the implementation of end of life care
guidance more generally, it is hoped that the findings of
this investigation will inform new workforce develop-
ment interventions to enhance the confidence and skills
of acute stroke staff in providing palliative and end of
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